223 related articles for article (PubMed ID: 31920949)
1. Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity.
Blair JC; Barrett MJ; Patrie J; Flanigan JL; Sperling SA; Elias WJ; Druzgal TJ
Front Neurol; 2019; 10():1329. PubMed ID: 31920949
[TBL] [Abstract][Full Text] [Related]
2. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
[TBL] [Abstract][Full Text] [Related]
3. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
4. Classification of PPMI MRI scans with voxel-based morphometry and machine learning to assist in the diagnosis of Parkinson's disease.
Solana-Lavalle G; Rosas-Romero R
Comput Methods Programs Biomed; 2021 Jan; 198():105793. PubMed ID: 33099263
[TBL] [Abstract][Full Text] [Related]
5. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
6. Brainstem atrophy in focal epilepsy destabilizes brainstem-brain interactions: Preliminary findings.
Mueller SG; Bateman LM; Nei M; Goldman AM; Laxer KD
Neuroimage Clin; 2019; 23():101888. PubMed ID: 31203171
[TBL] [Abstract][Full Text] [Related]
7. Prefrontal and hippocampal atrophy using 7-tesla magnetic resonance imaging in patients with Parkinson's disease.
Oh BH; Moon HC; Kim A; Kim HJ; Cheong CJ; Park YS
Acta Radiol Open; 2021 Feb; 10(2):2058460120988097. PubMed ID: 33786201
[TBL] [Abstract][Full Text] [Related]
8. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
[TBL] [Abstract][Full Text] [Related]
9. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
10. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
11. A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry.
Lee JE; Park B; Song SK; Sohn YH; Park HJ; Lee PH
Mov Disord; 2010 Jan; 25(1):28-34. PubMed ID: 19908327
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
13. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
[TBL] [Abstract][Full Text] [Related]
14. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
[TBL] [Abstract][Full Text] [Related]
15. Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.
Zhang J; Zhang YT; Hu WD; Li L; Liu GY; Bai YP
Int J Clin Exp Med; 2015; 8(9):15383-92. PubMed ID: 26629027
[TBL] [Abstract][Full Text] [Related]
16. Subcortical grey matter changes associated with motor symptoms evaluated by the Unified Parkinson's disease Rating Scale (part III): A longitudinal study in Parkinson's disease.
Charroud C; Turella L
Neuroimage Clin; 2021; 31():102745. PubMed ID: 34225020
[TBL] [Abstract][Full Text] [Related]
17. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
[TBL] [Abstract][Full Text] [Related]
18. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.
Barrett MJ; Sperling SA; Blair JC; Freeman CS; Flanigan JL; Smolkin ME; Manning CA; Druzgal TJ
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1251-1256. PubMed ID: 31175168
[TBL] [Abstract][Full Text] [Related]
19. Sex effects on brain structure in de novo Parkinson's disease: a multimodal neuroimaging study.
Tremblay C; Abbasi N; Zeighami Y; Yau Y; Dadar M; Rahayel S; Dagher A
Brain; 2020 Oct; 143(10):3052-3066. PubMed ID: 32980872
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure lability is associated with subcortical atrophy in early Parkinson's disease.
Yoo SW; Yun E; Bang M; Yoon U; Yoo JY; Lee KS; Shin NY; Kim JS
J Hypertens; 2020 Oct; 38(10):2043-2049. PubMed ID: 32890281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
